These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36351517)

  • 1. Gut microbiota and metabolites in myasthenia gravis: Early diagnostic biomarkers and therapeutic strategies.
    Kang Y; Li L; Kang X; Zhao Y; Cai Y
    Clin Immunol; 2022 Dec; 245():109173. PubMed ID: 36351517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbiota dysbiosis and myasthenia gravis: Do all roads lead to Rome?
    Kapoor B; Gulati M; Gupta R; Singla RK
    Autoimmun Rev; 2023 May; 22(5):103313. PubMed ID: 36918089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota as Regulators of Th17/Treg Balance in Patients With Myasthenia Gravis.
    Chen P; Tang X
    Front Immunol; 2021; 12():803101. PubMed ID: 35003133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the Gut Microbiome in Myasthenia Gravis.
    Thye AY; Law JW; Tan LT; Thurairajasingam S; Chan KG; Letchumanan V; Lee LH
    Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota and probiotics: novel immune system modulators in myasthenia gravis?
    Rinaldi E; Consonni A; Guidesi E; Elli M; Mantegazza R; Baggi F
    Ann N Y Acad Sci; 2018 Feb; 1413(1):49-58. PubMed ID: 29341125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metagenome-wide association study of gut microbiome revealed potential microbial marker set for diagnosis of pediatric myasthenia gravis.
    Liu P; Jiang Y; Gu S; Xue Y; Yang H; Li Y; Wang Y; Yan C; Jia P; Lin X; Qi G
    BMC Med; 2021 Jul; 19(1):159. PubMed ID: 34233671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gut Microbiome and Acute Leukemia: Implications for Early Diagnostic and New Therapies.
    Huang X; Cai H; Zhao Y; Kang Y
    Mol Nutr Food Res; 2024 Feb; 68(3):e2300551. PubMed ID: 38059888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota: a new insight into neurological diseases.
    Liu L; Wang H; Chen X; Xie P
    Chin Med J (Engl); 2023 Jun; 136(11):1261-1277. PubMed ID: 35830286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiota and metabolites in diabetic retinopathy: Insights into pathogenesis for novel therapeutic strategies.
    Cai Y; Kang Y
    Biomed Pharmacother; 2023 Aug; 164():114994. PubMed ID: 37301133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Gut Microbiota in Myasthenia Gravis.
    Qiu D; Xia Z; Jiao X; Deng J; Zhang L; Li J
    Front Microbiol; 2018; 9():2627. PubMed ID: 30483222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers of human gut microbiota diversity and dysbiosis.
    Rüb AM; Tsakmaklis A; Gräfe SK; Simon MC; Vehreschild MJ; Wuethrich I
    Biomark Med; 2021 Feb; 15(2):137-148. PubMed ID: 33442994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota Profiles in Early- and Late-Onset Colorectal Cancer: A Potential Diagnostic Biomarker in the Future.
    Abdullah M; Sukartini N; Nursyirwan SA; Pribadi RR; Maulahela H; Utari AP; Muzellina VN; Wiraatmadja A; Renaldi K
    Digestion; 2021; 102(6):823-832. PubMed ID: 34433172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Gut Microbiota and Fecal Metabolites Related With the Clinical Subtypes of Myasthenia Gravis.
    Tan X; Huang Y; Chai T; Zhao X; Li Y; Wu J; Zhang H; Duan J; Liang W; Yin B; Cheng K; Yu G; Zheng P; Xie P
    Front Microbiol; 2020; 11():564579. PubMed ID: 33013794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota microbial metabolites in diabetic nephropathy patients: far to go.
    Yu JX; Chen X; Zang SG; Chen X; Wu YY; Wu LP; Xuan SH
    Front Cell Infect Microbiol; 2024; 14():1359432. PubMed ID: 38779567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential roles of gut microbiota and microbial metabolites in Parkinson's disease.
    Zheng SY; Li HX; Xu RC; Miao WT; Dai MY; Ding ST; Liu HD
    Ageing Res Rev; 2021 Aug; 69():101347. PubMed ID: 33905953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on Ocular Myasthenia Gravis.
    O'Hare M; Doughty C
    Semin Neurol; 2019 Dec; 39(6):749-760. PubMed ID: 31847046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile myasthenia gravis: three case reports and a literature review.
    Gadient P; Bolton J; Puri V
    J Child Neurol; 2009 May; 24(5):584-90. PubMed ID: 19406758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myasthenia gravis and the neuromuscular junction.
    Querol L; Illa I
    Curr Opin Neurol; 2013 Oct; 26(5):459-65. PubMed ID: 23945282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Gut Microbiome and Hepatocellular Carcinoma: Implications for Early Diagnostic Biomarkers and Novel Therapies.
    Kang Y; Cai Y; Yang Y
    Liver Cancer; 2022 Apr; 11(2):113-125. PubMed ID: 35634424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.